GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Yew Bio-Pharm Group Inc (OTCPK:YEWB) » Definitions » Operating Margin %

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Operating Margin % : -956.36% (As of Sep. 2021)


View and export this data going back to 2013. Start your Free Trial

What is Yew Bio-Pharm Group Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Yew Bio-Pharm Group's Operating Income for the three months ended in Sep. 2021 was $-1.05 Mil. Yew Bio-Pharm Group's Revenue for the three months ended in Sep. 2021 was $0.11 Mil. Therefore, Yew Bio-Pharm Group's Operating Margin % for the quarter that ended in Sep. 2021 was -956.36%.

The historical rank and industry rank for Yew Bio-Pharm Group's Operating Margin % or its related term are showing as below:


YEWB's Operating Margin % is not ranked *
in the Consumer Packaged Goods industry.
Industry Median: 4.89
* Ranked among companies with meaningful Operating Margin % only.

Yew Bio-Pharm Group's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Yew Bio-Pharm Group's Operating Income for the three months ended in Sep. 2021 was $-1.05 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2021 was $-0.80 Mil.


Yew Bio-Pharm Group Operating Margin % Historical Data

The historical data trend for Yew Bio-Pharm Group's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yew Bio-Pharm Group Operating Margin % Chart

Yew Bio-Pharm Group Annual Data
Trend Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Operating Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.13 8.20 22.98 -2.43 9.29

Yew Bio-Pharm Group Quarterly Data
Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.77 0.11 7.82 -2.94 -956.36

Competitive Comparison of Yew Bio-Pharm Group's Operating Margin %

For the Farm Products subindustry, Yew Bio-Pharm Group's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yew Bio-Pharm Group's Operating Margin % Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Yew Bio-Pharm Group's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Yew Bio-Pharm Group's Operating Margin % falls into.



Yew Bio-Pharm Group Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Yew Bio-Pharm Group's Operating Margin % for the fiscal year that ended in Dec. 2020 is calculated as

Operating Margin %=Operating Income (A: Dec. 2020 ) / Revenue (A: Dec. 2020 )
=2.538 / 27.308
=9.29 %

Yew Bio-Pharm Group's Operating Margin % for the quarter that ended in Sep. 2021 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2021 ) / Revenue (Q: Sep. 2021 )
=-1.052 / 0.11
=-956.36 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yew Bio-Pharm Group  (OTCPK:YEWB) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Yew Bio-Pharm Group Operating Margin % Related Terms

Thank you for viewing the detailed overview of Yew Bio-Pharm Group's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Yew Bio-Pharm Group (Yew Bio-Pharm Group) Business Description

Traded in Other Exchanges
N/A
Address
9460 Telstar Avenue, Suite 6, El Monte, CA, USA, 91731
Yew Bio-Pharm Group Inc is a grower and seller of yew trees and manufacturer of products made from yew trees in China. The company also sells raw material, including the branches and leaves of yew trees, used in the manufacturing of traditional Chinese medicines, which are used as a secondary treatment for certain cancers, meaning they must be administered in combination with other pharmaceutical drugs. The company operating business segments are China and the United States, of which the majority of its revenue comes from China.
Executives
Yongchun Shi director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91302
Xiefeng Liu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Guoshuang Tian director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xuehai Wu director 9460 TELSTAR AVENUE, SUITE 6 EL MONTE CA 91731
Xingming Han director DOOR 3, FLOOR 7, VIC NO.23 TONGZHAN ST. XIANGFANG DISTRICT HARBIN CITY F4 XXXXXXXXX
Adam C Wasserman officer: Chief Financial Officer 1643 ROYAL GROVE WAY, WESTON FL 33327
Guifang Qi director, officer: Treasurer 501 N. MOORE AVE. APT. A MONTEREY PARK CA 91754
Zhiguo Wang director, officer: President and Secretary NO. 234, GEXIN STREET NANGANG DISTRICT HARBIN CITY F4 XXXXXXXXX

Yew Bio-Pharm Group (Yew Bio-Pharm Group) Headlines

From GuruFocus

Yew Bio-Pharm Group Announces New Significant Agreement

By Marketwired Marketwired 09-12-2018

Yew Bio-Pharm Group Announces New Cosmetic Subsidiary

By Marketwired Marketwired 03-09-2021